Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine.

Saved in:
Bibliographic Details
Title: Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine.
Authors: WENGER, KATHARINA J.1,2, BURGER, MICHAEL C.1,2, VOSS, MARTIN1,2, RONELLENFITSCH, MICHAEL W.1,2, STEINBACH, JOACHIM P.1,2, BÄHR, OLIVER1,2, WAGNER, MARLIES1,3, SE‑JONG YOU1,3, FRANZ, KEA1,4, HARTER, PATRICK N.1,5, FOKAS, EMMANOUIL1,6
Source: Oncology Letters. Jul2017, Vol. 14 Issue 1, p1141-1146. 6p. 2 Charts, 2 Graphs.
Database: Academic Search Ultimate
Description
ISSN:17921074
DOI:10.3892/ol.2017.6251